Effect of antidepressants on the activity of stress-responsive systems

Organizational Data

DRKS-ID:
DRKS00000008
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2008-09-05
Last update in DRKS:
2017-04-02
Registration type:
Retrospective

Acronym/abbreviation of the study

No Entry

URL of the study

No Entry

Brief summary in lay language

Randomized-open, 4-week antidepressant therapy with venlafaxine vs. mirtazapine in patients with unipolar depression as well as 6-month follow-up

Brief summary in scientific language

Randomized-open, 4-week antidepressant therapy with venlafaxine vs. mirtazapine in patients with unipolar depression as well as 6-month follow-up

Health condition or problem studied

ICD10:
F32 - Depressive episode
ICD10:
F33 - Recurrent depressive disorder
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Mirtazapin
Arm 2:
venlafaxine

Endpoints

Primary outcome:
Hamilton Depression Rating Scale: <8 = remission -50% = response
Secondary outcome:
No Entry

Study Design

Purpose:
Treatment
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
III
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
No
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
No Entry

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Germany
Number of study centers:
Monocenter study
Recruitment location(s):
No Entry

Recruitment period and number of participants

Planned study start date:
No Entry
Actual study start date:
2003-04-15
Planned study completion date:
No Entry
Actual Study Completion Date:
2007-12-31
Target Sample Size:
120
Final Sample Size:
No Entry

Inclusion Criteria

Sex:
All
Minimum Age:
18 Years
Maximum Age:
75 Years
Additional Inclusion Criteria:
major depression (DSM-IV) Hamilton Depression Rating Scale-21 item version: at least 18

Exclusion Criteria

bipolar depression Depression due to an organic or substance factor substance dependency lifetime diagnosis of schizophrenia glucocorticoid therapy

Addresses

Primary Sponsor

Address:
Zentralinstitut für Seelische Gesundheit
Prof. Dr. med. Michael Deuschle
J5
68159 Mannheim
Germany
Telephone:
+49 621 1703 2331
Fax:
+49 621 1703 2325
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
Zentralinstitut für Seelische Gesundheit
Prof. Dr. med. Michael Deuschle
J5
68159 Mannheim
Germany
Telephone:
+49 621 1703 2331
Fax:
+49 621 1703 2325
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Contact for Public Queries

Address:
Zentralinstitut für Seelische Gesundheit
Prof. Dr. med. Michael Deuschle
J5
68159 Mannheim
Germany
Telephone:
+49 621 1703 2331
Fax:
+49 621 1703 2325
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Principal Investigator

Address:
Zentralinstitut für Seelische Gesundheit
Prof. Dr. med. Michael Deuschle
J5
68159 Mannheim
Germany
Telephone:
+49 621 1703 2331
Fax:
+49 621 1703 2325
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Sources of Monetary or Material Support

Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)

Address:
DFG - Deutsche Forschungsgemeinschaft
Kennedyallee 40
53175 Bonn
Germany
Telephone:
+49 228 885 1
Fax:
+49 228 885 2777
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Ethics Committee

Address Ethics Committee

Address:
Med. Ethik-Kommission II, Fakultät für Medizin Mannheim, Ruprecht-Karls-Universität Heidelberg [Medizinische Ethik-Kommission II Medizinische Fakultät Mannheim der Universität Heidelberg]
Prof. Dr. med. Jens-Peter Striebel
Maybachstrasse 14-16
68169 Mannheim
Germany
Telephone:
+49 621 3363 440
Fax:
-49 621 3363 442
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.ma.uni-heidelberg.de/inst/ethikkommission/

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2003-04-09
Ethics committee number:
0255.6
Vote of the Ethics Committee:
Approved
Date of the vote:
2003-04-15

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No Entry
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry